In an effort to defend medical devices against quantum attacks, MIT researchers have engineered an ultra-efficient microchip that can protect wireless biomedical devices, such as insulin pumps and pacemakers, reports Katie Hunt for CNN. The microchip, which is around the size of an extremely fine needle tip, “includes built-in protection needed for post-quantum cybersecurity. The device achieved between 20 and 60 times higher energy efficiency than other post-quantum security techniques.”
Prof. Regina Barzilay speaks with WBUR’s Priyanka Dayal McCluskey about her work developing an AI risk detection tool that can analyze mammogram images and help predict risk of breast cancer before it happens or spreads. Barzilay, who describes the tool as a hi-tech weather forecast for breast health, notes that: “We really need to have tools that can help, rather than just staring at an image and trying to guess.”
Reporting for CNN, Caleb Hellerman spotlights how MIT computer scientists developed an AI program called Sybil that can “‘look’ at a single CT scan and generate a ‘risk score’ corresponding to the likelihood of the person developing cancer over any period up to six years.”
Prof. Marzyeh Ghassemi speaks with Mark Herz, host of GBH Morning Edition, about the potential benefits and issues associated with using AI in medicine. “Where I really see a lot of fantastic opportunity is identifying spaces where humans don’t have a fundamental capacity, like early breast cancer detection where it’s a sub-clinical presentation,” says Ghassemi. “These are spaces where humans cannot do or have been proven not to be good at a very specific clinical task. And there, AI can really help close the gap.”
Writing for Forbes, Senior Lecturer Guadalupe Hayes-Mota 08, SM '16, MBA '16 explores how businesses can best prepare for the rapid advancements underway in the field of neurotechnology. “I believe that one of the most important steps companies can take regarding this emerging technology is to act now, without waiting for regulatory clarity first,” writes Hayes-Mota. “Treat neural data as categorically sensitive from day one—not because you are forced to, but because you understand that operating this close to the human mind demands a higher threshold of trust than almost any technology before it.”
Prof. Pat Pataranutaporn speaks with The Guardian reporter Andrew Gregory about the lack of safety warnings and disclaimers in AI overviews, specifically in AI-generated health materials. “The absence of disclaimers when users are initially served medical information creates several critical dangers,” says Pataranutaporn. “Disclaimers serve as a crucial intervention point. They disrupt this automatic trust and prompt users to engage more critically with the information they receive.”
A new study by researchers at MIT and elsewhere has found a correlation between addiction and eye care, reports Hadley Barndollar for MassLive. “The study found nearly half of the patients with opioid use disorder being treated for the eye infection were eligible to initiate medication-assisted treatment,” explains Barndollar. “But medications were only initiated when an addiction consult occurred, highlighting how much more eye doctors responding to emergency rooms can offer patients beyond vision care.”
Senior Research Scientist Leo Anthony Celi speaks with New York Times reporter Gina Kolata about the use of AI in health care. “The real concern isn’t AI itself,” says Celi. “It’s the AI is being deployed to optimize a profoundly broken system rather than to reimagine it.”
Researchers at MIT have developed a wearable breast cancer ultrasound device that could be used to detect breast cancer earlier, reports Amerigo Allegretto for AuntMinnie.com. “The device can image as deep as 15 cm into breast tissue and can image the entire breast from two or three locations,” explains Allegretto. “The team described the technology as an end-to-end system ultrasound architecture consisting of a novel sparse array geometry and a codesigned data acquisition system.”
Prof. Marzyeh Ghassemi and Monica Agrawal PhD '23 speak with Boston Globe reporter Hiawatha Bray about the risks on relying solely on AI for medical information. “What I’m really, really worried about is economically disadvantaged communities,” says Ghassemi. “You might not have access to a health care professional who you can quickly call and say, ‘Hey… Should I listen to this?’”
Prof. Jonanthan Gruber speaks with Boston 25 reporter Amal Elhelw about increased health insurance premiums. “It’s an enormous emotional toll,” says Gruber. “It’s just not a stress we should put on people in a nation as wealthy as America.”
MassLive reporter Scott Kirsner spotlights Claire Beskin MBA '22, CEO and founder of Empallo, a virtual clinic for heart care aimed at preventing cardiac issues before they happen. “It handles everything from scheduling to prescriptions to billing,” writes Kirsner. “Empallo’s approach, Beskin said, is ‘virtual first,’ meaning it tries to give patients an online consult with a doctor when possible, and send them into the office when necessary.”
Prof. Jonathan Gruber speaks with David Frum from The Atlantic’s “The David Frum Show” to shed light on the American healthcare system and health care disparities. “The issue in the U.S. is there are the haves and the have-nots—the haves get comparable health care to the rest of the world at a much higher price; the have-nots get worse health care at a much higher price,” says Gruber. “There’s really two fundamental challenges in U.S. health care: There’s disparities, and there’s costs.”
Prof. Hugh Herr speaks with Bloomberg Businessweek Daily host Carol Massar and Tim Stenovec about his work creating bionic limbs that combine human physiology with electromechanics. “I really realized how limited the current prosthetic technology was and I dedicated my life as a young man to really advance the field and enable extraordinary technology that will allow people to do what they want again, to move again and have the bodies that they seek," says Herr.
Writing for Forbes, Senior Lecturer Guadalupe Hayes-Mota 08, SM '16, MBA '16 explains the CARES framework, a new model for founders looking to integrate ethics into their company. “Biotechnology can cure, extend and transform life,” writes Hayes-Mota. “But based on my experiences, its full potential can only be realized when innovation and ethics advance together. To every scientist-founder at the edge of discovery: How can your business plan not only explain how you’ll succeed, but also why your success should exist?”